Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

> Eli Lilly is down 5% because the market for their most profitable drug, a $125k/yr mAb IL-17 inhibitor, fell 5%. This is why Novartis, their major competitor with Cosentyx, is also down the same amount

> Not everything is about Twitter!

https://twitter.com/quantian1/status/1591149510168039426



So I suppose they're pulling Twitter ad spend for other reasons? I guess this whole fiasco is still damaging to their brand.


https://www.reuters.com/business/healthcare-pharmaceuticals/...

Ads may have gone down for a number of factors, may also include the fact that Twitter is not really in a place that is good for advertising due to enormous amounts of hostile users

The "damaging tweet" in question was gone long before the stock would've been in a reasonable timeframe to "react" to it.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: